The Latin America, Middle East and Africa Fibromyalgia Treatment Market would witness market growth of 7.4% CAGR during the forecast period (2023-2030).
The market is expected to rise due to several factors, including rising research and development costs for searching for novel therapies for treating fibromyalgia and the approval and introduction of novel medications. In addition, fibromyalgia treatment is expected to be driven by increased generic fibromyalgia treatment pharmaceutical adoption, which will increase the medication's affordability. Major firms actively pursue growth and acquisitions to expand their product lines and reach more customers.
Prominent businesses all over the region are acquiring businesses with a high number of product recalls to maintain their market position. The market is anticipated to rise due to the expanding government programs that offer manufacturers and healthcare professionals advice regarding fibromyalgia. Such regulations are predicted to help the affected population manage their fibromyalgia and spread knowledge of the disorder.
South Africa is home to 57.3 million people, 8.3% over 60. The number and percentage of senior adults in South Africa is projected to increase by 5.7 million (9.1% of the population) by 2022, from 3.3 million (7.2% of the population) in 2002 to 4.0 million (7.7% of the population) in 2012. Consequently, compared to 31% for the population under 60, it is anticipated that the number of elderly individuals will increase by 69.9% over the period. The population over 60 is increasing by 2.7% annually, approximately twice as quickly as under 60 (1.4%). As older people are more likely to experience pain-related issues like fibromyalgia, the need for fibromyalgia treatment is anticipated to surge, boosting the market growth in the region.
The Brazil market dominated the LAMEA Fibromyalgia Treatment Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $69.4 million by 2030. The Argentina market is exhibiting a CAGR of 8% during (2023 - 2030). Additionally, The UAE market would experience a CAGR of 7.1% during (2023 - 2030).
Based on Drug Class, the market is segmented into Anticonvulsants, Antidepressants, Muscle Relaxants and Others. Based on Distribution Channel, the market is segmented into Drug stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Fibromyalgia Treatment Market is Projected to reach USD 4 Billion by 2030, at a CAGR of 4.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Novartis AG, Eli Lilly And Company, Amneal Pharmaceuticals, Inc., Teva Pharmaceuticals Industries Ltd., Zydus Lifesciences Ltd., Lupin Limited, Abbott Laboratories, Viatris, Inc., and Sun Pharmaceutical Industries Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Drug Class
- Anticonvulsants
- Antidepressants
- Muscle Relaxants
- Others
By Distribution Channel
- Drug stores & Retail Pharmacies
- Hospital Pharmacies
- Online Providers
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- AbbVie, Inc.
- Novartis AG
- Eli Lilly And Company
- Amneal Pharmaceuticals, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Zydus Lifesciences Ltd.
- Lupin Limited
- Abbott Laboratories
- Viatris, Inc.
- Sun Pharmaceutical Industries Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Fibromyalgia Treatment Market, by Drug Class
1.4.2 LAMEA Fibromyalgia Treatment Market, by Distribution Channel
1.4.3 LAMEA Fibromyalgia Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Fibromyalgia Treatment Market by Drug Class
3.1 LAMEA Anticonvulsants Market by Country
3.2 LAMEA Antidepressants Market by Country
3.3 LAMEA Muscle Relaxants Market by Country
3.4 LAMEA Others Market by Country
Chapter 4. LAMEA Fibromyalgia Treatment Market by Distribution Channel
4.1 LAMEA Drug stores & Retail Pharmacies Market by Country
4.2 LAMEA Hospital Pharmacies Market by Country
4.3 LAMEA Online Providers Market by Country
Chapter 5. LAMEA Fibromyalgia Treatment Market by Country
5.1 Brazil Fibromyalgia Treatment Market
5.1.1 Brazil Fibromyalgia Treatment Market by Drug Class
5.1.2 Brazil Fibromyalgia Treatment Market by Distribution Channel
5.2 Argentina Fibromyalgia Treatment Market
5.2.1 Argentina Fibromyalgia Treatment Market by Drug Class
5.2.2 Argentina Fibromyalgia Treatment Market by Distribution Channel
5.3 UAE Fibromyalgia Treatment Market
5.3.1 UAE Fibromyalgia Treatment Market by Drug Class
5.3.2 UAE Fibromyalgia Treatment Market by Distribution Channel
5.4 Saudi Arabia Fibromyalgia Treatment Market
5.4.1 Saudi Arabia Fibromyalgia Treatment Market by Drug Class
5.4.2 Saudi Arabia Fibromyalgia Treatment Market by Distribution Channel
5.5 South Africa Fibromyalgia Treatment Market
5.5.1 South Africa Fibromyalgia Treatment Market by Drug Class
5.5.2 South Africa Fibromyalgia Treatment Market by Distribution Channel
5.6 Nigeria Fibromyalgia Treatment Market
5.6.1 Nigeria Fibromyalgia Treatment Market by Drug Class
5.6.2 Nigeria Fibromyalgia Treatment Market by Distribution Channel
5.7 Rest of LAMEA Fibromyalgia Treatment Market
5.7.1 Rest of LAMEA Fibromyalgia Treatment Market by Drug Class
5.7.2 Rest of LAMEA Fibromyalgia Treatment Market by Distribution Channel
Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.2 AbbVie, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Novartis AG
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 Eli Lilly And Company
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 Amneal Pharmaceuticals, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.5.4 Research & Development Expenses
6.6 Teva Pharmaceutical Industries Ltd.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.7 Zydus Lifesciences Ltd.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Trials and Approvals:
6.8 Lupin Limited
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Recent strategies and developments:
6.8.3.1 Trials and Approvals:
6.9 Viatris, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental Analysis
6.9.4 Research & Development Expense
6.10. Sun Pharmaceutical Industries Ltd.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expenses
TABLE 1 LAMEA Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 3 LAMEA Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 4 LAMEA Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 5 LAMEA Anticonvulsants Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Anticonvulsants Market by Country, 2023 - 2030, USD Million
TABLE 7 LAMEA Antidepressants Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Antidepressants Market by Country, 2023 - 2030, USD Million
TABLE 9 LAMEA Muscle Relaxants Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Muscle Relaxants Market by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 12 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 13 LAMEA Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 14 LAMEA Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 15 LAMEA Drug stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Drug stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 17 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 19 LAMEA Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Fibromyalgia Treatment Market by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Fibromyalgia Treatment Market by Country, 2023 - 2030, USD Million
TABLE 23 Brazil Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 24 Brazil Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 25 Brazil Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 26 Brazil Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 27 Brazil Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 28 Brazil Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 29 Argentina Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 30 Argentina Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 31 Argentina Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 32 Argentina Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 33 Argentina Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 Argentina Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 35 UAE Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 36 UAE Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 37 UAE Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 38 UAE Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 39 UAE Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 40 UAE Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 41 Saudi Arabia Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 42 Saudi Arabia Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 43 Saudi Arabia Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 44 Saudi Arabia Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 45 Saudi Arabia Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 46 Saudi Arabia Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 47 South Africa Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 48 South Africa Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 49 South Africa Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 50 South Africa Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 51 South Africa Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 52 South Africa Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 53 Nigeria Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 54 Nigeria Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 55 Nigeria Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 56 Nigeria Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 57 Nigeria Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Nigeria Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 59 Rest of LAMEA Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 60 Rest of LAMEA Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 61 Rest of LAMEA Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 62 Rest of LAMEA Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 63 Rest of LAMEA Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 64 Rest of LAMEA Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 65 Key Information – Abbott Laboratories
TABLE 66 Key information – AbbVie, Inc.
TABLE 67 Key Information – Novartis AG
TABLE 68 Key Information – Eli Lilly And Company
TABLE 69 Key Information – Amneal Pharmaceuticals, INc.
TABLE 70 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 71 Key Information – Zydus Lifesciences Ltd.
TABLE 72 Key Information – Lupin Limited
TABLE 73 key information – Viatris, Inc.
TABLE 74 Key Information – Sun Pharmaceutical Industries Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Fibromyalgia Treatment Market share by Drug Class, 2022
FIG 3 LAMEA Fibromyalgia Treatment Market share by Drug Class, 2030
FIG 4 LAMEA Fibromyalgia Treatment Market by Drug Class, 2019 - 2030, USD Million
FIG 5 LAMEA Fibromyalgia Treatment Market share by Distribution Channel, 2022
FIG 6 LAMEA Fibromyalgia Treatment Market share by Distribution Channel, 2030
FIG 7 LAMEA Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2030, USD Million
FIG 8 LAMEA Fibromyalgia Treatment Market share by Country, 2022
FIG 9 LAMEA Fibromyalgia Treatment Market share by Country, 2030
FIG 10 LAMEA Fibromyalgia Treatment Market by Country, 2019 - 2030, USD Million
FIG 11 Swot analysis: Abbott laboratories